FDA Approves Combination Of Ezetimibe And Atorvastatin
The FDA has approved a new combination drug from Merck for lowering cholesterol. The drug, which will carry the brand name of Liptruzet, is a combination of two previously approved cholesterol-lowering drugs, ezetimibe and atorvastatin. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 3, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

FDA approves Merck combination cholesterol lowering pill
(Reuters) - The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - May 3, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Merck’s LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol
Dateline City:  WHITEHOUSE STATION, N.J. LIPTRUZET Approved for Patients with Primary or Mixed Hyperlipidemia, as an Adjunct to Diet When Diet Alone Is Not Enough Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved LIPTRUZET™(ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet w...
Source: Merck.com - Corporate News - May 3, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: Research and Development News Corporate News Latest News Source Type: news

Pfizer Cuts Outlook
Pfizer's first-quarter revenue fell 9% and the drug maker lowered its full-year outlook, as the company struggles to replace billions of dollars in lost sales of cholesterol fighter Lipitor. (Source: WSJ.com: Health)
Source: WSJ.com: Health - May 1, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

Benefit of statins for impotence uncertain
Conclusion Overall, this study provides some evidence that treatment for six weeks with atorvastatin (Lipitor) improved some measures of erectile dysfunction (but not to within the normal range) compared with vitamin E or placebo. There are some limitations to this study, some of which are described by the authors: As this study only included men who had previously had their erectile dysfunction treated with sildenafil (Viagra) and showed no improvement, the study findings do not apply to men yet to receive drug therapy for their erectile dysfunction. This study was of short duration (six weeks), so long-term out...
Source: NHS News Feed - April 23, 2013 Category: Consumer Health News Tags: Medication Source Type: news

Blood Sample Mismatch Leads 'Anguished' Authors To Retract Three Lipitor Papers
Three substudies of the influential TNT (Treating to New Targets) trial have been retracted after the sponsor of the trial, Pfizer, discovered that blood samples from the study had been matched to the wrong participants. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 16, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Generic drug costs $133 less at Costco than CVS
CVS charges $150 for a monthly prescription of the generic version of the cholesterol drug Lipitor. The same drug goes for $17 at Costco. (Source: WDSU.com - Health)
Source: WDSU.com - Health - April 3, 2013 Category: Consumer Health News Source Type: news

Consumer Reports: Generic drug prices vary by store
Consumer Reports secret shoppers found generic Lipitor at Costco costs $17, compared to $150 at CVS (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 28, 2013 Category: Consumer Health News Source Type: news

High-dose statins 'raise risk of serious kidney problems'
High-dose statins taken by millions of people are putting them at increased risk of potentially fatal kidney problems, researchers are warning. (Source: Telegraph Health)
Source: Telegraph Health - March 20, 2013 Category: Consumer Health News Tags: rosustatin kidney simvastatin AKI lipitor atorvastatin crestor Source Type: news

Free Atorvastatin From WegmansFree Atorvastatin From Wegmans
The free generic medication is available only to those with a prescription, but the hope is that the grocery store gains new customers by offering to fill these prescriptions at their pharmacies for no cost. Heartwire (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 18, 2013 Category: Cardiology Tags: Cardiology News Source Type: news

Free statins in aisle 6: US supermarket chain giving away atorvastatin
The free generic medication is available only to those with a prescription, but the hope is that the grocery store gains new customers by offering to fill these prescriptions at their pharmacies for no cost. (Source: theHeart.org)
Source: theHeart.org - March 15, 2013 Category: Cardiology Source Type: news

Clopidogrel/atorvastatin protect in carotid stenting
A 600-mg clopidogrel load and a short-term reload with high-dose atorvastatin provided neuroprotection in patients undergoing carotid stenting. (Source: theHeart.org)
Source: theHeart.org - March 14, 2013 Category: Cardiology Source Type: news

Clopidogrel/Atorvastatin Protect in Carotid StentingClopidogrel/Atorvastatin Protect in Carotid Stenting
A 600-mg clopidogrel load and a short-term reload with high-dose atorvastatin provided neuroprotection in patients undergoing carotid stenting. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 14, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

ACC: Statin Plus Plavix Aids in Carotid Stenting (CME/CE)
SAN FRANCISCO (MedPage Today) -- A higher loading dose of clopidogrel (Plavix) along with a reload of atorvastatin (Lipitor) was neuroprotective in patients having carotid stenting, researchers reported here. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 14, 2013 Category: Cardiology Source Type: news

Do We Really Need Head-To-Head Comparison Trials With Statins To Improve Cardiac Health?
Actually, not all statins are alike. Clinical studies have shown, and it is accepted by CV experts around the world, that atorvastatin lowers LDL to a significantly greater extent than simvastatin. One might argue, however, that greater lowering of LDL might not be very meaningful in a real world setting, that all that is necessary is to get LDL below a certain threshold to reduce the risk of heart attacks in at-risk patients. That’s a fair point and, with no real world head-to-head clinical data to confirm this, belief that greater LDL lowering is more beneficial is an article of faith. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 1, 2013 Category: Pharmaceuticals Authors: John LaMattina Source Type: news